Drug repurposing for COVID-19: a potential threat of self-medication and controlling measuresписьмо
Аннотация: Dear Editor,
We read with great interest a recent editorial published in Postgraduate Medical Journal ,1 suggesting the potential harms associated with the use of unproven antimicrobials for the management of COVID-19. We appreciate the efforts of authors to underscore the potential drug safety concerns during the ongoing health crisis. In align with these suggestions, we felt inclined to share another potential hazard associated during the current phase of drug repurposing.
COVID-19 has encompassed more than 200 countries with unprecedented rise in infected cases along with mortalities. Healthcare professionals and researchers around the globe are battling hard to combat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and taking all possible measures to reduce the growing encumbrance of the disease. Since most of the countries have imposed lockdown and people are confining to their homes with restricted movements, they are more vigilant for the updates on COVID-19, particularly on treatments and preventive measures. Most of the people are relying on electronic media and social networking to get latest and updated information related to the disease. On the other hand, increasing numbers of COVID-19-related deaths are creating panic among the general public. In such circumstances, both general and healthcare communities are anxiously waiting to receive any positive news regarding the treatment and prevention of infection. Literature has reported several medications such as hydroxychloroquine (HCQ) and chloroquine (CQ)2 carrying the potential to cure COVID-19. Most of these reports primarily rely on invitro investigations and lack firm clinical evidences from human studies.3 4 5 Though such a hypothesis, generations for the treatment of COVID-19 are the need of hour, but uncontrolled amplified dissemination of news or information by the lay press, electronic and social media may trigger self-medication of candidate drugs among general community. It is pertinent to mention that …
Год издания: 2020
Авторы: Tauqeer Hussain Mallhi, Yusra Habib Khan, Nasser Hadal Alotaibi, Abdulaziz Ibrahim Alzarea, Abdullah Salah Alanazi, Sumera Qasim, Muhammad Shahid Iqbal, Nida Tanveer
Издательство: Oxford University Press
Источник: Postgraduate Medical Journal
Ключевые слова: COVID-19 Clinical Research Studies, Antibiotic Use and Resistance, SARS-CoV-2 and COVID-19 Research
Другие ссылки: Postgraduate Medical Journal (PDF)
Postgraduate Medical Journal (HTML)
PubMed Central (HTML)
PubMed (HTML)
Postgraduate Medical Journal (HTML)
PubMed Central (HTML)
PubMed (HTML)
Открытый доступ: hybrid
Том: 97
Выпуск: 1153
Страницы: 742–743